Matthew D’Ambrosio
Director/Miembro de la Junta en BRIGHTSPRING HEALTH SERVICES, INC. .
Fortuna: 10 410 $ al 30/04/2024
Perfil
Matthew D’Ambrosio currently works at BrightSpring Health Services, Inc., as Independent Director from 2022.
Mr. D’Ambrosio also formerly worked at Sumitomo Pharma America, Inc., as Chief Compliance & Ethics Office from 2010 to 2017 and Reliant Pharmaceuticals LLC, as Chief Compliance Office.
Mr. D’Ambrosio received his Masters Business Admin degree from Rutgers State University of New Jersey, undergraduate degree from Rider University, and graduate degree from Seton Hall University School of Law.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
20/05/2024 | 1 000 ( 0.00% ) | 10 410 $ | 30/04/2024 |
Cargos activos de Matthew D’Ambrosio
Empresas | Cargo | Inicio |
---|---|---|
BRIGHTSPRING HEALTH SERVICES, INC. | Director/Miembro de la Junta | 01/10/2022 |
Antiguos cargos conocidos de Matthew D’Ambrosio.
Empresas | Cargo | Fin |
---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Oficial de Cumplimiento | 01/11/2017 |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Oficial de Cumplimiento | - |
Formación de Matthew D’Ambrosio.
Rutgers State University of New Jersey | Masters Business Admin |
Rider University | Undergraduate Degree |
Seton Hall University School of Law | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BRIGHTSPRING HEALTH SERVICES, INC. | Health Services |
Empresas privadas | 2 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
- Bolsa de valores
- Insiders
- Matthew D’Ambrosio